Biocon expands portfolio & market reach with $3.3B buyout of Viatris biosimilars February 28, 2022 Auto Bot Biocon Biologics, Biologic Drugs, BioPharma, biopharma nl, deals, India, Pennsylvania, Pharma, Viatris 0 Biocon Biologics is acquiring the biosimilars business of its longtime partner, Viatris. The deal gives Biocon a biosimilars presence in both emerging and developed markets, while Viatris sheds non-core assets as part of a broader strategic review.